Table 2 Clinical characteristic of adult PLHIV in public health facilities of Ethiopia, September 2013 to August 2014
Characteristics | Number (Percentage) |
|---|---|
Care status | |
On pre-ART care | 397 (5.1) |
On ART | 7429 (94.9) |
Total | 7826 (100.0) |
WHO clinical staging | |
Stage I/II | 6880 (88.9) |
Stage III/IV | 855 (11.1) |
Total | 7735 (100.0) |
Functional status | |
Working | 7479 (96.8) |
Ambulatory/bed ridden | 251 (3.2) |
Total | 7730 (100.0) |
Nutritional status | |
Severe/moderate thinness | 421 (7.9) |
Mild thinness | 771 (14.4) |
Normal | 3430 (64.3) |
Overweight/obese | 715 (13.4) |
Total | 5337 (100.0) |
CD4 count (cells/mm3) | |
< 200 | 951 (15.4) |
200–349 | 1553 (25.1) |
350–499 | 1556 (25.1) |
≥500 | 2127 (34.4) |
Total | 6187 (100.0) |
TB symptoms screening result | |
Positive | 428 (5.6) |
Negative | 7184 (94.4) |
Total | 7612 (100.0) |
Isoniazid prophylaxis | |
Yes | 1703 (24.8) |
No | 5170 (75.2) |
Total | 6873 (100.0) |
Adherence to ART | |
Good | 5689 (88.2) |
Poor/fair | 764 (11.8) |
Total | 6453 (100.0) |
Cotrimoxazole prophylaxis | |
Yes | 5135 (97.1) |
No | 154 (2.9) |
Total | 5289 (100.0) |
Median duration of stay in HIV care (months) | 56 (IQR = 28–80) |
Median CD4 count (cells/ mm3) | 407 (IQR = 261–572) |